For those who might be interested, I received the message below from PhotoPharmics today providing an update to a light therapy clinical trial that I have been tracking for close to a year:
Celeste Light for PD Trial Update
Hello!
We want to update you about the status of our pivotal clinical trial (which can also be called a phase 3 trial). On top of FDA Breakthrough Device designation, we're pleased to let you know we expect to begin recruiting in December of this year.
Kent Savage, CEO of PhotoPharmics said, “Multiple forces have aligned to make the timing for our pivotal clinical study here and now. We have leveraged this time to work with FDA, gather input from our clinical advisory board, and coordinate with the trial team at the University of Rochester. Once we finalize related funding details, recruitment will begin in earnest.”
Savage added, “Fortunately, demand for non-pharmaceutical and non-invasive solutions like Celeste from people with Parkinson’s and their care partners has only increased. We have heard from thousands of people patiently waiting for the opportunity to experience the benefits of Celeste.”
You're welcome to view the announcement here.
photopharmics.com/newsroom/...
A big thanks for your patience! We will alert you via email once the website for recruiting becomes available.
Best!
Brett Walker
SVP, Marketing
PhotoPharmics
Trial info on clinicaltrials.gov
DB RCT for Specialized Phototherapy in Parkinson's Disease. (LIGHT-PD)
Here is the link: